HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

A “Waking Giant” In Food Safety? Experts Discuss China’s Future Of Reform

This article was originally published in The Tan Sheet

Executive Summary

"It should come as no surprise if China emerges as a leader in food safety reform," United Natural Products Alliance Executive Director Loren Israelsen said

You may also be interested in...



China food safety efforts

China will spend 8.8 bil. yuan ($1.1 bil.) during the next three to five years to strengthen food and drug oversight and infrastructure, China's State Food and Drug Administration Spokeswoman Yan Jiangying said during a press conference in Beijing Aug. 8. Approximately 6.3 bil. yuan ($790 mil.) will be funded by the central government for initiatives in Western and Central China, while the rest will come from local governments in Eastern China, she added. On May 24, SFDA announced the "2007 National Plan of Special Rectification of Food Safety" to improve the safety of food eaten in China and exported food (1"The Tan Sheet" June 4, 2007, p. 12). In other safety news, Yan noted SFDA has released a list of Web sites that may legally sell drugs online, including four retail sites authorized to sell nonprescription drugs to consumers...

China Commits To Tightening Food Safety Supervision As MOA Talks Begin

A spokesman at the Chinese embassy in Washington says China will intensify its food safety supervision as U.S. and Chinese officials in Beijing begin work on a memorandum of agreement on food and feed safety

Drug Firms Model Ensuring Import Safety; China’s Inconsistencies Worry FDA

Firms using Chinese imports to make dietary supplements and other products can look to drug firms for lessons on ensuring the safety of raw materials from China, where adherence to food and drug production regulations remains inconsistent, current and former FDA executives tell a Senate panel

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel